Literature DB >> 21069478

Biochemical, pathological and oncological relevance of Gb3Cer receptor.

D Đevenica1, V Čikeš Čulić, A Vuica, A Markotić.   

Abstract

Glycosphingolipids are amphipathic molecules composed of hydrophilic oligosaccharide chain and a hydrophobic ceramide part, located primarily in the membrane microdomains of animal cells. Their oligosaccharide chains make them excellent candidates for the cell surface recognition molecules. Natural glycosphingolipid, globotriaosylceramide (Gal α1-4, Gal β1-4, Glc β1-1, ceramide), is also called CD77 and its expression was previously associated with proliferating centroblasts undergoing somatic hypermutation, but it has been demonstrate that globotriaosylceramide is not a reliable marker to discriminate human centroblasts from centrocytes. Globotriaosylceramide constitutes rare P k blood group antigen on erythrocytes, and it is also known as Burkitt's lymphoma antigen. On endothelial cells, globotriaosylceramide plays as the receptor for bacterial toxins of the Shiga family, also called verotoxins. Precise biological function and significance of globotriaosylceramide expression on endothelial cells remains to be the subject of many studies and it is believed globotriaosylceramide represents an example of a glycolipid antigen able to transduce a signal leading to apoptosis. In past decade, cancer researches put a great afford in determining new therapeutic agents such as bacterial toxins against tumor malignancies. Reports have demonstrated that verotoxin-1 induces apoptosis in solid tumor cell lines expressing globotriaosylceramide such as astrocytoma, renal cell carcinoma, colon cancer and breast cancer due to verotoxin-1 high specificity and apoptosis-inducing properties, and therefore, it is suggested to be an anticancer agent. Verotoxins have been investigated weather they could reduce treatment side-effects and toxicity to normal tissues and become a new oncological tool in cancer labeling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21069478     DOI: 10.1007/s12032-010-9732-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  117 in total

1.  Shiga toxin induces tubular membrane invaginations for its uptake into cells.

Authors:  Winfried Römer; Ludwig Berland; Valérie Chambon; Katharina Gaus; Barbara Windschiegl; Danièle Tenza; Mohamed R E Aly; Vincent Fraisier; Jean-Claude Florent; David Perrais; Christophe Lamaze; Graça Raposo; Claudia Steinem; Pierre Sens; Patricia Bassereau; Ludger Johannes
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

2.  Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.

Authors:  H Ling; A Boodhoo; B Hazes; M D Cummings; G D Armstrong; J L Brunton; R J Read
Journal:  Biochemistry       Date:  1998-02-17       Impact factor: 3.162

3.  Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance.

Authors:  Kazushige Kiguchi; Yuriko Iwamori; Nao Suzuki; Yoichi Kobayashi; Bunpei Ishizuka; Isamu Ishiwata; Tsunekazu Kita; Yoshihiro Kikuchi; Masao Iwamori
Journal:  Cancer Sci       Date:  2006-09-21       Impact factor: 6.716

4.  The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.

Authors:  N Haicheur; E Bismuth; S Bosset; O Adotevi; G Warnier; V Lacabanne; A Regnault; C Desaymard; S Amigorena; P Ricciardi-Castagnoli; B Goud; W H Fridman; L Johannes; E Tartour
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

5.  Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2.

Authors:  Beth Binnington; Daniel Lingwood; Anita Nutikka; Clifford A Lingwood
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

6.  Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin.

Authors:  P B Eisenhauer; P Chaturvedi; R E Fine; A J Ritchie; J S Pober; T G Cleary; D S Newburg
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

7.  Structural basis of the preferential binding for globo-series glycosphingolipids displayed by Pseudomonas aeruginosa lectin I.

Authors:  Bertrand Blanchard; Alessandra Nurisso; Emilie Hollville; Cécile Tétaud; Joelle Wiels; Martina Pokorná; Michaela Wimmerová; Annabelle Varrot; Anne Imberty
Journal:  J Mol Biol       Date:  2008-08-22       Impact factor: 5.469

Review 8.  Gangliosides as therapeutic targets for cancer.

Authors:  Pam Fredman; Kristina Hedberg; Thomas Brezicka
Journal:  BioDrugs       Date:  2003       Impact factor: 5.807

9.  The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization.

Authors:  Nacilla Haicheur; Fabrice Benchetrit; Mohamed Amessou; Claude Leclerc; Thomas Falguières; Catherine Fayolle; Emmanuelle Bismuth; Wolf H Fridman; Ludger Johannes; Eric Tartour
Journal:  Int Immunol       Date:  2003-10       Impact factor: 4.823

10.  CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis.

Authors:  A A Khine; M Firtel; C A Lingwood
Journal:  J Cell Physiol       Date:  1998-08       Impact factor: 6.384

View more
  12 in total

1.  Carbohydrate-containing molecules as potential biomarkers in colon cancer.

Authors:  Eun Ji Joo; Amanda Weyers; Guoyun Li; Leyla Gasimli; Lingyun Li; Won Jun Choi; Kyung Bok Lee; Robert J Linhardt
Journal:  OMICS       Date:  2014-02-06

2.  Identification of a novel streptococcal adhesin P (SadP) protein recognizing galactosyl-α1-4-galactose-containing glycoconjugates: convergent evolution of bacterial pathogens to binding of the same host receptor.

Authors:  Annika Kouki; Sauli Haataja; Vuokko Loimaranta; Arto T Pulliainen; Ulf J Nilsson; Jukka Finne
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

3.  Structure-dependent pseudoreceptor intracellular traffic of adamantyl globotriaosyl ceramide mimics.

Authors:  Mitsumasa Saito; Murugespillai Mylvaganum; Patty Tam; Anton Novak; Beth Binnington; Clifford Lingwood
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

Review 4.  Sphingolipids and Lymphomas: A Double-Edged Sword.

Authors:  Alfredo Pherez-Farah; Rosa Del Carmen López-Sánchez; Luis Mario Villela-Martínez; Rocío Ortiz-López; Brady E Beltrán; José Ascención Hernández-Hernández
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

5.  Shiga toxin 1, as DNA repair inhibitor, synergistically potentiates the activity of the anticancer drug, mafosfamide, on raji cells.

Authors:  Maurizio Brigotti; Valentina Arfilli; Domenica Carnicelli; Laura Rocchi; Cinzia Calcabrini; Francesca Ricci; Pasqualepaolo Pagliaro; Pier Luigi Tazzari; Roberta R Alfieri; Pier Giorgio Petronini; Piero Sestili
Journal:  Toxins (Basel)       Date:  2013-02-21       Impact factor: 4.546

6.  Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds.

Authors:  Lev Stimmer; Sabrina Dehay; Fariba Nemati; Gerald Massonnet; Sophie Richon; Didier Decaudin; Jerzy Klijanienko; Ludger Johannes
Journal:  BMC Cancer       Date:  2014-12-04       Impact factor: 4.430

7.  Endoplasmic Reticulum-Targeted Subunit Toxins Provide a New Approach to Rescue Misfolded Mutant Proteins and Revert Cell Models of Genetic Diseases.

Authors:  Humaira Adnan; Zhenbo Zhang; Hyun-Joo Park; Chetankumar Tailor; Clare Che; Mustafa Kamani; George Spitalny; Beth Binnington; Clifford Lingwood
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

8.  Streptococcal Adhesin P (SadP) contributes to Streptococcus suis adhesion to the human intestinal epithelium.

Authors:  Maria Laura Ferrando; Niels Willemse; Edoardo Zaccaria; Yvonne Pannekoek; Arie van der Ende; Constance Schultsz
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

Review 9.  Verotoxin Receptor-Based Pathology and Therapies.

Authors:  Clifford Lingwood
Journal:  Front Cell Infect Microbiol       Date:  2020-03-31       Impact factor: 5.293

10.  The Two Sweet Sides of Janus Lectin Drive Crosslinking of Liposomes to Cancer Cells and Material Uptake.

Authors:  Lina Siukstaite; Francesca Rosato; Anna Mitrovic; Peter Fritz Müller; Katharina Kraus; Simona Notova; Anne Imberty; Winfried Römer
Journal:  Toxins (Basel)       Date:  2021-11-09       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.